1型糖尿病儿童启动Tandem Control-IQ后的真实世界血糖与患者报告结局
这项多中心前瞻性观察队列研究纳入13家比利时中心连续招募的114例6-18岁1型糖尿病儿童,评估启动Control-IQ后1年的血糖与患者报告结局变化。启动后12个月,血糖范围内时间从51.6%升至64.4%,HbA1c从62 mmol/mol降至54 mmol/mol,低血糖时间从3.9%降至2.7%,生活质量改善且缺课缺勤减少。
要点
- 启动Control-IQ后12个月血糖范围内时间从51.6%升至64.4%(P<0.001)。
- HbA1c从62 mmol/mol降至54 mmol/mol,低血糖时间从3.9%降至2.7%(均P<0.001)。
- 儿童与家长生活质量改善,缺课缺勤减少(均P<0.001)。
核心结论
- 使用Control-IQ一年与血糖管理改善、糖尿病相关生活质量提高以及缺课缺勤减少相关。
研究设计与样本
- 多中心前瞻性观察队列研究,2021年12月至2022年12月在13家比利时中心连续招募所有启动Control-IQ的6-18岁1型糖尿病儿童。
- 共纳入114例儿童,平均年龄12.0±3.2岁,其中61.4%为女孩。
- 在启动时及第4、8、12个月收集数据,患者报告结局通过DQOLY、HFS、HAPPI-D问卷评估。
主要发现
- 血糖范围内时间(3.9-10.0 mmol/L)从启动时51.6%(47.6-55.5)增至12个月64.4%(61.2-67.5)(P<0.001)。
- 12个月后HbA1c从62 mmol/mol(60-65)即7.8%(7.6-8.1)降至54 mmol/mol(52-57)即7.1%(6.9-7.3)(P<0.001)。
- 12个月后血糖低于3.9 mmol/L的时间从3.9%(3.1-4.8)降至2.7%(1.9-3.5)(P<0.001)。
- 儿童DQOLY满意度评分从70.4分(67.8-73.0)升至74.0分(71.3-76.6),DQOLY影响评分从54.6分(50.9-58.3)降至51.3分(47.4-55.1)(均P<0.001)。
- 家长HAPPI-D评分从22.5分(21.1-23.9)降至19.6分(18.2-21.0),HFS担忧评分从25.0分(21.6-28.4)降至20.3分(17.0-23.5)(均P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Real-world data add value to outcomes from randomized controlled trials on the use of hybrid closed-loop systems in the management of children and adolescents with type 1 diabetes. OBJECTIVE: This multicenter prospective observational cohort study assessed real-world changes in glycemic and person-reported outcomes 1 year after Control-IQ initiation in children and adolescents with type 1 diabetes. METHODS: Between December 2021 and December 2022, all children aged 6-18 years who started Control-IQ at 13 Belgian centers were consecutively recruited. Data were collected at start of Control-IQ and after 4, 8, and 12 months. Person-reported outcomes were evaluated through questionnaires (Diabetes Quality of Life for Youth [DQOLY], Hypoglycemia Fear Survey [HFS], HAPPI-D). Data are reported as mean ± SD or least-squares mean (95% CI). RESULTS: A total of 114 children were included, with a mean age of 12.0 ± 3.2 years and of whom 61.4% were girls. Time in range (3.9-10.0 mmol/L) increased from start (51.6% [47.6-55.5]) to 12 months (64.4% [61.2-67.5]) (P < 0.001). After 12 months, HbA1c decreased from 62 mmol/mol (60-65) (7.8% [7.6-8.1]) to 54 mmol/mol (52-57) (7.1% [6.9-7.3]) and time <3.9 mmol/L from 3.9% (3.1-4.8) to 2.7% (1.9-3.5) (all P < 0.001). Children scored better on DQOLY satisfaction (70.4 [67.8-73.0] vs 74.0 points [71.3-76.6]) and DQOLY impact (54.6 [50.9-58.3] vs 51.3 points [47.4-55.1]), and parents on HAPPI-D (22.5 [21.1-23.9] vs 19.6 points [18.2-21.0]) and HFS worry (25.0 [21.6-28.4] vs 20.3 points [17.0-23.5]) (all P < 0.001). Children missed fewer days of school (287 vs 30 days/100 person-years, P < 0.001) and parents missed fewer days of work (247 vs 47 days/100 person-years, P < 0.001). CONCLUSION: One-year use of Control-IQ was associated with improved glycemic management, more diabetes-related quality of life and fewer school/work absences.
引用
- De Meulemeester J, Valgaerts L, Massa G, et al. Real-World Glycemic and Person-Reported Outcomes After Tandem Control-IQ Initiation in Children With Type 1 Diabetes. J Clin Endocrinol Metab. 2025. PMID: 40333328. doi:10.1210/clinem/dgaf265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。